Achema middle east

Press Releases

DiscoverX Partners with B’SYS GmbH to Expand SAFETYscan In Vitro Pharmacological Profiling Services

DiscoverX Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development announced their partnership with B’SYS GmbH to expand DiscoverX’s SAFETYscan in vitro pharmacological profiling services for ion channel assays. SAFETYscan services provide...

Eyevensys receives French regulatory approval to advance EyeCET platform

Eyevensys, a private biotechnology company developing its proprietary EyeCET platform, the first non-viral gene expression technology that enables the safe, local, sustained production of therapeutic proteins in the eye to address a wide range of ophthalmic diseases. ...

Imanova Receives £1M Award from the MRC To Develop Early Markers of Dementia – the MIND-MAPS Study

Following a £0.5m Medical Research Council (MRC) grant to implement new Positron Emission Tomography (PET) imaging tracers for mitochondrial dysfunction and synaptic loss. Imanova has been awarded an additional £1m of strategic funding from the MRC...

Hardware+Tools Middle East firmly set on growth path

Hardware Tools Middle East looks ahead to a successful 2017 edition, with interest from hardware and tools manufacturers continuing, as market sentiments begin to stabilise across the region.  Despite signs of slowing demand in other regions,...

AstraZeneca’s Tagrisso gains full FDA approval for lung cancer

AstraZeneca announced that the US FDA has granted full approval for Tagrisso (osimertinib) 80mg once-daily tablets, for the treatment of patients with metastatic EGFR T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, whose disease...

TraceLink Announces NEXUS 17 Keynote Speakers

TraceLink Inc., the world’s largest Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace.  Announced the latest keynote speakers confirmed for NEXUS 17, the industry’s...

Botanix receives export and import approvals for clinical studies from DEA

Botanix Pharmaceuticals is pleased to announce that the US Drug Enforcement Agency (DEA) has approved the export, and the Australian Office of Controlled Substances (ODC) has approved the import of synthetic cannabidiol for Botanix’s planned clinical studies. ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »